Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Integrin avb6 in Idiopathic Pulmonary Fibrosis, Primary Sclerosing Cholangitis, and Coronavirus Disease 2019 With [18F]FP-R01-MG-F2 With PET/CT

NCT03183570 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT03183570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03183570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Integrin avb6 in Idiopathic Pulmonary Fibrosis, Primary Sclerosing Cholangitis, and Coronavirus Disease 2019 With [18F]FP-R01-MG-F2 With PET/CT
Lead sponsor
Stanford University
Phase
Phase 1
Overall status
Completed
Start date
November 8, 2017
Completion date
January 25, 2025
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19 pneumonia, idiopathic pulmonary fibrosis, primary sclerosing cholangitis